755 filings
Page 2 of 38
S-8 POS
AERI
Aerie Pharmaceuticals Inc
21 Nov 22
Registration of securities for employees (post-effective amendment)
11:33am
8-K
AERI
Aerie Pharmaceuticals Inc
21 Nov 22
Entry into a Material Definitive Agreement
10:01am
25-NSE
The Nasdaq Stock Market LLC
21 Nov 22
Exchange delisting
8:56am
8-K
AERI
Aerie Pharmaceuticals Inc
18 Nov 22
Submission of Matters to a Vote of Security Holders
4:55pm
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
10 Nov 22
AERIE PHARMACEUTICALS / MORGAN STANLEY ownership change
4:06pm
DEFA14A
AERI
Aerie Pharmaceuticals Inc
7 Nov 22
Additional proxy soliciting materials
5:17pm
8-K
AERI
Aerie Pharmaceuticals Inc
7 Nov 22
Other Events
9:20am
4
Jeffrey Calabrese
3 Nov 22
AERIE PHARMACEUTICALS / Jeffrey Calabrese ownership change
7:41pm
10-Q
2022 Q3
AERI
Aerie Pharmaceuticals Inc
Quarterly report
3 Nov 22
5:39pm
8-K
AERI
Aerie Pharmaceuticals Inc
3 Nov 22
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:07pm
DEFM14A
AERI
Aerie Pharmaceuticals Inc
7 Oct 22
Proxy related to merger
9:06am
PREM14A
AERI
Aerie Pharmaceuticals Inc
21 Sep 22
Preliminary proxy related to merger
5:16pm
8-K
AERI
Aerie Pharmaceuticals Inc
13 Sep 22
Regulation FD Disclosure
4:01pm
DEFA14A
AERI
Aerie Pharmaceuticals Inc
23 Aug 22
Additional proxy soliciting materials
5:15pm
8-K
AERI
Aerie Pharmaceuticals Inc
23 Aug 22
Entry into a Material Definitive Agreement
5:13pm
DEFA14A
AERI
Aerie Pharmaceuticals Inc
23 Aug 22
Additional proxy soliciting materials
10:21am
DEFA14A
AERI
Aerie Pharmaceuticals Inc
22 Aug 22
Additional proxy soliciting materials
9:40pm
8-K
AERI
Aerie Pharmaceuticals Inc
22 Aug 22
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
9:37pm
4
John LaRocca
16 Aug 22
AERIE PHARMACEUTICALS / John LaRocca ownership change
4:16pm
4
Jeffrey Calabrese
16 Aug 22
AERIE PHARMACEUTICALS / Jeffrey Calabrese ownership change
4:14pm